Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AbbVie’s Newly Licensed Drug Scores Against Crohn’s Disease
AbbVie’s Newly Licensed Drug Scores Against Crohn’s Disease
AbbVie’s Newly Licensed Drug Scores Against Crohn’s Disease
Submitted by
admin
on May 24, 2016 - 11:54pm
Source:
Investors.com
News Tags:
AbbVie
Crohn's Disease
risankizumab
Boehringer Ingelheim
Headline:
AbbVie’s Newly Licensed Drug Scores Against Crohn’s Disease
Do Not Allow Advertisers to Use My Personal information
